Clinical trial
OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.
NCT00277524
Study timeline
Study start (unknown)2005-08-01Date precision: month
Registry last updated2013-08-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Tachycardia, Ventricularunresolved
Heart Failure, Congestiveunresolved
Ventricular Fibrillationunresolved
Ventricular Dysfunctionunresolved
Bradycardiaunresolved
Interventions
Sponsors & collaborators
Medtronic Cardiac Rhythm and Heart Failurelead sponsor
Medtroniccollaborator
Mapped research locations
New YorkNew York, United States3St LouisMissouri, United States2HoustonTexas, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1AtlantaGeorgia, United States1San AntonioTexas, United States1CincinnatiOhio, United States1San DiegoCalifornia, United States1TampaFlorida, United States1PortlandOregon, United States1MinneapolisMinnesota, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00277524 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.